Πίνακας περιεχομένων:

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	DQIS Research Group
Μορφή:	Recurso digital
Γλώσσα:	Αγγλικά
Έκδοση:	Zenodo 2026
Θέματα:	tail dependence Clayton copula Tumor Microenvironment Hypoxia evolutionary dynamics cancer immunosurveillance TASE", "Tissue-Aware Stemness Exclusion Channel-internal context-dependent gating Three classes of safety mechanism synNotch master switch
Διαθέσιμο Online:	https://doi.org/10.5281/zenodo.20024757
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Πίνακας περιεχομένων:

Supplementary analysis to the DQIS Consolidated Framework v30.0 (Zenodo DOI: 10.5281/zenodo.19855263). This addendum addresses the tail dependence concern raised in the consolidated framework, demonstrating that it decomposes into two mechanistically distinct problems with different temporal signatures: (1) Evolutionary Tail Dependence (ETD): requires sustained selective pressure over many cell generations. At the DQIS early interception window (10² cells, ~10 generations), ETD probability is ~0.03% — negligible for the operational claim. Formal boundary: ETD < 5% for all tumours with M < 10⁴ cells and G < 50 generations. (2) Environmental Tail Dependence (EnTD): arises from shared microenvironmental stressors (hypoxia, acidosis) without mutation. Present from earliest tumour stages; spatially bounded; correctly modelled by Clayton copula. Empirical analysis on GSE72056 (1,257 malignant melanoma cells) confirms T-γ* + T-ε as the pair with lowest empirical lower tail dependence (LTD ≈ 0). v30.0 update: the T-α/T-δ LTD=0.25 previously observed is now causally explained by the ACLY→acetyl-CoA→HAT pathway (O33) — a constitutive metabolic-epigenetic component, not purely environmental. Design B (T-δ v2.0 CIN) eliminates this component, reducing T-α/T-δ LTD to ~0.05–0.10. Version 16.0 principal updates (May 2026). Cross-references aligned to Consolidated v30 and Objections Register v30. Section 16 added: Design B impact on tail dependence calculus — inter-group correlation correction (θ_ME=0.40–0.50 via ACLY, O33), Monte Carlo validation of Design B vs current design, T-δ v2.0 CIN sensor deployment conditions, revised EnTD assessment with Design B. Section 16.5 added: Adaptive Quorum Architecture integration — formal proof that k=1/N + Gate_G shifts security from statistical rarity to biological specificity; ETD immunity under adaptive quorum demonstrated (loss-of-function across all N channels AND Ki-67 suppression is biologically self-defeating); P_escape(k=1, Gate_G) ≈ (p_i)^N × p_G where p_G ≈ 0.01, giving ~300,000× for N=3; required Gate_G validation experiments specified. Safety architecture (v16.0, four classes). Class 1: Quorum-level k-of-N consensus with balanced M/E groups (Sections 2–8). Class 2: Population-level IPS module for biophysically-cold tumours (Sections 10–12). Class 3: Channel-internal context-dependent gating — TASE (T-γ* v3.1, Section 13) + Gate_G (T-γ* v3.2, §3.1b.7 Consolidated v30). Class 4: Manufacturing-phase fratricide prevention — separate GMP sub-pool expansion (O30). Class 5 (v16.0): Adaptive Quorum Architecture — k=1/N + Gate_G biological specificity gate, orthogonal to all five biophysical channels via CDK4/6-Rb-E2F pathway independence (Section 16.5). Direct empirical measurements (May 2026). GBM (GSE131928, 7,911 IDHwt cells): θ=0.199 — NOT cold, reclassified. PDAC (GSE155698, 11,448 EPCAM+ cells): θ=1.214 — confirmed cold, IPS module resolves. Normal pancreas (GSE84133, 5,432 cells): θ=1.107 — intrinsically cold (PDX1/HNF1B/PTF1A), not KRAS-induced. Penetrance discovery: IPS 15.5× PDAC vs normal, 10.1× IPMN precancerous. Not a peer-reviewed publication. Prior art deposit — CC BY 4.0. Contact: dqis.research@proton.me Related documents: - DQIS Consolidated Framework (main document): https://zenodo.org/records/19877553 - Register of Scientific Objections v4.0: https://zenodo.org/records/19880166

Παρόμοια τεκμήρια